CGI-1746

Overview

CGI-1746 is a potent and highly selective inhibitor of the Btk with IC 50 of 1.9 nM.

Application

Products | Products > Disease Areas > Autoimmune Disease | Products > Disease Areas > Arthritis | Products > Disease Areas > Leukemia/Lymphoma/Myeloma | Products > Disease Areas > Blood Disease | Products > Disease Areas > Rheumatoid Arthritis | Products > Disease Areas > Cancer | Products > Disease Areas > Inflammation or Immune System Disease | Products > Disease Areas > Blood or Cardio-cerebrovascular Disease | Products > Disease Areas > Musculoskeletal and Skin Disease | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Autophagy | Products > Research Areas > Inflammation/Immunology | Products > Signaling Pathways > Btk | Products > Signaling Pathways > Autophagy

Product Information

• Catalog No.: HY-11999
• CAS No.: 910232-84-7
• Molecular Formula: C34H37N5O4
• Molecular Weight: 579.69
• Purity: 99.25%
• Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 2 years , -20°C, 1 year
• Solubility: ≥ 2.5 mg/mL (4.31 mM); Clear solution
• Availability: In-stock

Source

Original product source